The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
An open label, phase 1b/2 trial of LVGN6051 (4-1BB agonistic antibody) combined with anlotinib for refractory soft tissue sarcoma (STS).
 
Yan Zhou
No Relationships to Disclose
 
Xianan Li
No Relationships to Disclose
 
Linqing Li
No Relationships to Disclose
 
Peng Zhang
No Relationships to Disclose
 
Zhaoming Ye
No Relationships to Disclose
 
Binghao Li
No Relationships to Disclose
 
Yong Chen
No Relationships to Disclose
 
Jian Zhang
No Relationships to Disclose
 
Xiaomin Ding
No Relationships to Disclose
 
Qunzi Zhang
No Relationships to Disclose
 
Qiyuan Tan
No Relationships to Disclose
 
Chunhao Zhang
No Relationships to Disclose
 
Zhichang Zhang
No Relationships to Disclose
 
Ting Yuan
No Relationships to Disclose
 
Weiping Ji
No Relationships to Disclose
 
Qingcheng Yang
No Relationships to Disclose
 
Yang Dong
No Relationships to Disclose
 
Jieyi Wang
Employment - Lyvgen Biopharma
Leadership - Lyvgen Biopharma
Stock and Other Ownership Interests - Lyvgen Biopharma
Patents, Royalties, Other Intellectual Property - patents at Abbott, AbbVie, and Lyvgen
Travel, Accommodations, Expenses - Lyvgen Biopharma
 
C. Hubert Chan
Employment - Lyvgen Biopharma
 
Haiyan Hu
No Relationships to Disclose